Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]Ga-DOTA-(RGD)2 PET/CT Imaging of Activated Endothelium in Lung Parenchyma of COVID-19 Patients

NCT04596943 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04596943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04596943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]Ga-DOTA-(RGD)2 PET/CT Imaging of Activated Endothelium in Lung Parenchyma of COVID-19 Patients
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
October 15, 2020
Completion date
March 1, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, endothelial dysfunction, pet imaging